Global HIV & AIDS figures According to the latest global statistics on the status of AIDS epidemic, in 2016, 36.7 million people were living with…
morava
Today it was announced that the use of the only approved Dengue vaccine, Dengvaxia, is to be strictly limited due to evidence it can worsen…
The biennial International AIDS Conference, AIDS2018, is the world’s biggest healthcare conference and will be held in Amsterdam from July 23rd to 27th, 2018. Over 20.000 healthcare professionals…
NanoDSF and MicroScaleThermophoresis (MST) are two groundbreaking technologies concerning protein-ligand binding assay offered by our development partner Proteros GMBH. Used in conjunction, these technologies offer a cost-effective…
Today the final agreement was signed through which biotech company First Health Pharmaceuticals transferred large part of its pipeline of highly active antivirus agents concerning…
The latest results of a wide range of cell culture assays of some of our compounds against triple negative metastatic breast cancer, metastatic (smokers) lung…
Our research clearly points towards an important role of DDX3 overexpression in cancer. We have already had very positive test results in breast cancer but…
The DDX3 RNA Helicase is a known host factor for a wide array of viruses of which many are already investigated by our group. Some…
World AIDS Day 2016 – December 1 Substantial progress is being made, but more than half of all HIV patients are still untreated. According to…
Besides investigating and optimising the efficacy, toxicity and deliverability of our antiviral compounds, we also started three closely related research projects. One focuses on the…